Summary of Conditions for Coverage and Clinical Standards established by CMS final rule CMS-3818-F (effective October 14, 2008). The rule reorganizes ESRD Conditions for Coverage into new 42 CFR part 494 and clarifies patient-safety, patient-care, and administrative expectations for Medicare-certified dialysis facilities.
Medicare ESRD Conditions for Coverage were reissued in final rule CMS-3818-F effective October 14, 2008 (with some compliance delays for select provisions). The new part 494 emphasizes patient safety, patient care, and administration, consolidating prior requirements and incorporating contemporary infection control and water/dialysate standards by reference.
Infection control: CMS incorporated by reference CDC RR05 (Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients), expanding the incorporation to include the full narrative 'Recommendations' section (pages 18–28) except CDC screening recommendations for hepatitis C. The CDC hemodialysis infection control practices incorporated by reference are mandatory for survey compliance. Facilities must implement standard infection control precautions (dedication or proper cleaning of items taken to dialysis stations; use of leak-proof containers for contaminated hemodialyzers; medication preparation in a centralized clean area; strategic placement of gloves rather than allowing staff to carry gloves in pockets). Management of HBsAg-positive patients must follow CDC guidance: separate room and equipment where possible, or separation by buffer zones/demarcated physical spaces and dedicated supplies/equipment; facilities must have capacity to separate HBsAg-positive patients. Facilities required separate staff assignment precautions for HBV-positive care (staff may care for immune patients concurrently but not susceptible patients). Surveyors will enforce RR05 practices as mandatory despite the original guideline language of 'should.' Waiver provisions and compliance time extensions (e.g., 300 days for isolation room retrofits) are provided where retrofit would be burdensome.
Infection control program oversight: CMS removed a specific RN 'infection control officer' requirement and instead required that infection control be addressed as a required topic within the facility QAPI program (§494.110). Clinical staff must report infection control issues to the facility medical director and the quality improvement committee. Patient education must include infection prevention and personal care topics and facilities should educate patients on infection control practices and their role in preventing spread.
Testing and surveillance: Diagnostic hepatitis panel coverage follows existing Medicare NCD guidance — an elevated serum transaminase (ICD-9-CM 790.4) is a covered indication allowing hepatitis panel testing, and monthly ALT included in the composite payment can trigger a covered hepatitis C antibody test when elevated. Facilities must analyze and document infections, establish baselines, monitor trends, and report communicable diseases per law.
Water and dialysate quality: CMS incorporated by reference ANSI/AAMI RD52:2004 (Dialysate for Hemodialysis) and RD62:2001 (Water Treatment Equipment) and adopted AAMI action-level concepts and monitoring/testing locations. Requirements include at least two granular activated carbon tanks in series (minimum iodine number 900 when GAC used), empty bed contact time guidance (at least 5 minutes per bed), chlorine/chloramine testing frequency (beginning of day and before each shift; if no set shifts, then every 4 hours), dialysate bacterial cultures accompanied by endotoxin testing when adverse events are suspected, and adherence to manufacturer timeframes for mixed bicarbonate concentrate (incorporating AAMI language rather than prescriptive new limits). Facilities must monitor water/dialysate quality for home hemodialysis patients per manufacturer and FDA labeling for preconfigured systems; bacteriologic and endotoxin testing at least quarterly or more frequently as needed.
Reuse and reprocessing: CMS incorporated ANSI/AAMI RD47:2002/A1:2003 'Reuse of Hemodialyzers' by reference and retained AAMI-based requirements: only dialyzers and bloodlines labeled for reuse may be reprocessed; follow manufacturer and AAMI guidance; prohibition on reuse for hepatitis B patients; use a single germicide per reprocessed dialyzer (with clarification regarding bleach), refrigeration permitted when reprocessing delayed, and suspension of reuse when suspected adverse events occur. Facilities using outside reprocessing services remain responsible for patient safety and for testing/evaluation when clusters of adverse events occur.
Operational coverage items: Water sampling sites follow AAMI RD52 guidance (first and last outlets of distribution loop, outlets for reuse equipment and bicarbonate mixing tanks). Facilities must have corrective action plans for action levels and perform cultures and endotoxin testing with suspected water-related adverse events. Ultrapure dialysate is not required but facilities choosing it must meet RD52 section 4.3.2.2. Home hemodialysis systems must meet AAMI RD52 where applicable; facility must perform onsite evaluations and at least quarterly bacteriologic and endotoxin testing for home systems.
Physical environment and emergency preparedness: Staff surveillance of patients during hemodialysis is required (patients must be in view of staff; video does not meet this). Emergency preparedness plans must address fire, power/equipment failure, water interruption, care-related emergencies, and natural disasters, with staff and patient training at least annually. Facilities must provide an alternate emergency contact number for patients and contact local disaster management agencies at least annually. AED or defibrillator required; LSC provisions applied with exemptions for sprinkler installations in existing facilities (new facilities must comply). Waivers available for certain LSC provisions; 300-day compliance allowances for some physical plant changes (e.g., sprinklers, isolation rooms).
Patients' rights, assessment, and plan of care: Facilities must inform patients of rights (including advance directives and modality options), provide resource information for modalities not offered, and ensure patients are informed within initial treatments. Facilities must perform comprehensive interdisciplinary assessments (team includes patient or designee, RN, physician, MSW, RD) and complete initial assessment and implement plan of care within 30 days or 13 hemodialysis sessions (whichever is later); follow-up comprehensive reassessment at 3 months after initial assessment; stable patients reassessed at least annually; unstable patients monthly. The plan of care must address dialysis dose/volume control (hemodialysis Kt/V ≥ 1.2 or PD weekly Kt/V ≥ 1.7 or equivalent professional standard), nutritional status (monitor serum albumin and weight monthly; additional indicators as appropriate), anemia management (individualized consistent with evidence-based standards; use of lowest effective ESA dosing), vascular access monitoring and timely referrals, psychosocial status using a standardized tool chosen by the MSW, modality planning (including home dialysis and transplant candidacy with tracking), rehabilitation referrals, and mineral metabolism/renal bone disease management. Interdisciplinary team must sign the plan of care, document patient refusal to sign when applicable, and involve the patient in planning when desired. Physicians or permitted practitioner extenders must perform face-to-face visits at least monthly (physician, NP, CNS, or PA permitted). Transplant center communication required at least annually and when transplant candidate status changes.
Care at home: Home dialysis training must be conducted under RN oversight; facilities must document competency, retrieve and review self-monitoring data at least every 2 months, provide periodic home visits in accordance with plan of care, and supply/purchase/lease/rent/deliver/install/repair/maintain home dialysis equipment and supplies as prescribed. Home water/dialysate monitoring and onsite evaluation/testing must follow manufacturer instructions and FDA labeling for preconfigured systems; quarterly bacteriologic and endotoxin testing at minimum.
QAPI and infection control integration: Facilities must develop, implement, maintain, and evaluate a data-driven QAPI program with participation by professional interdisciplinary team members. Required QAPI topics include adequacy of dialysis, nutritional status, anemia management, vascular access (including fistula use and catheter reduction), medical injuries and errors, hemodialyzer reuse program, patient satisfaction and grievances, mineral metabolism/renal bone disease, and infection control (incorporating CDC RR05 details). Facility-level clinical performance standards will be developed through a voluntary consensus process before enforcement; CMS will publish proposed facility-level standards in the Federal Register.
Special purpose and emergency-converted facilities: Special purpose renal dialysis facilities (vacation camps/emergency conversions) may be approved to furnish dialysis short-term and must demonstrate compliance with specified subsets of part 494 conditions (infection control, selected water/dialysate standards, plan of care elements, certain personnel and governance responsibilities). Emergency flexibility and waiver processes are acknowledged; contact with patient's physician 'if possible' prior to initiating treatment and forwarding patient care documentation to the home facility 'if possible' within 30 days are required.
Laboratory services: Facilities must provide or make available laboratory services that meet patient needs; laboratories must meet CLIA requirements under 42 CFR part 493. Issues of centralized billing and electronic data exchange are operational and payment matters outside the Conditions for Coverage text but facilities may enter arrangements with labs for electronic data transmission to Networks.
Personnel, medical director, and governance: Staff must meet applicable State scope-of-practice and licensure requirements. Medical director must be a board-certified physician in internal medicine or pediatrics with completion of a board-approved nephrology training program and experience; the medical director is accountable to the governing body for the quality of medical care and must ensure adherence to policies (including admissions, infection control). Facility personnel qualification standards specify RN experience requirements for nurse manager/charge nurse/staff nurses, registered dietitian with at least 1 year professional experience in clinical nutrition, MSW social worker (with a grandfather clause for certain long-tenured non-MSW social workers), patient care dialysis technicians subject to state or national certification timelines, and training program elements for water technicians and PCTs.
Medical records and retention: Patient records must be maintained and retained for six years from discharge, transfer, or death in accordance with HIPAA (45 CFR 164.530(j)(2)). Facilities must ensure timely transfer of essential patient records to receiving facilities when patients travel or transfer, recognizing some flexibility in emergency scenarios.
Key operational callouts:
- Infection control practices from CDC RR05 are mandatory and enforced in surveys; facilities must incorporate RR05 'Recommendations' (pages 18–28) by reference except hepatitis C screening language.
- ANSI/AAMI RD52:2004 and RD62:2001 water/dialysate standards and ANSI/AAMI RD47 reuse standards are incorporated by reference and establish monitoring, action levels, and testing frequencies (including endotoxin testing with cultures when adverse events suspected).
- Facilities must complete initial patient assessment and implement individualized plan of care within 30 days or 13 HD sessions; follow-up reassessment at 3 months; unstable patients reassessed monthly.
- Medical director must be board-certified in internal medicine or pediatrics, complete nephrology training, and is accountable to the governing body for care quality.
- Patient records retained 6 years; timely transfer of records expected, with allowances in disaster situations.